These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 33370393)

  • 1. Evaluating comparative effectiveness of psychosocial interventions adjunctive to opioid agonist therapy for opioid use disorder: A systematic review with network meta-analyses.
    Rice D; Corace K; Wolfe D; Esmaeilisaraji L; Michaud A; Grima A; Austin B; Douma R; Barbeau P; Butler C; Willows M; Poulin PA; Sproule BA; Porath A; Garber G; Taha S; Garner G; Skidmore B; Moher D; Thavorn K; Hutton B
    PLoS One; 2020; 15(12):e0244401. PubMed ID: 33370393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating comparative effectiveness of psychosocial interventions for persons receiving opioid agonist therapy for opioid use disorder: protocol for a systematic review.
    Rice DB; Hutton B; Poulin P; Sproule BA; Wolfe D; Moher D; Thavorn K; Garber G; Taha S; Porath A; Willows M; Esmaeilisaraji L; Yazdi F; Shea B; Skidmore B; Corace K
    BMJ Open; 2018 Oct; 8(10):e023902. PubMed ID: 30341139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative efficacy and acceptability of psychosocial interventions for individuals with cocaine and amphetamine addiction: A systematic review and network meta-analysis.
    De Crescenzo F; Ciabattini M; D'Alò GL; De Giorgi R; Del Giovane C; Cassar C; Janiri L; Clark N; Ostacher MJ; Cipriani A
    PLoS Med; 2018 Dec; 15(12):e1002715. PubMed ID: 30586362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relative effectiveness of medications for opioid-related disorders: A systematic review and network meta-analysis of randomized controlled trials.
    Lim J; Farhat I; Douros A; Panagiotoglou D
    PLoS One; 2022; 17(3):e0266142. PubMed ID: 35358261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opioid-related treatment, interventions, and outcomes among incarcerated persons: A systematic review.
    Malta M; Varatharajan T; Russell C; Pang M; Bonato S; Fischer B
    PLoS Med; 2019 Dec; 16(12):e1003002. PubMed ID: 31891578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Buprenorphine versus methadone for the treatment of opioid dependence: a systematic review and meta-analysis of randomised and observational studies.
    Degenhardt L; Clark B; Macpherson G; Leppan O; Nielsen S; Zahra E; Larance B; Kimber J; Martino-Burke D; Hickman M; Farrell M
    Lancet Psychiatry; 2023 Jun; 10(6):386-402. PubMed ID: 37167985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opioid Agonist Therapies and Pregnancy Outcomes for Pregnant People With Opioid Use Disorder: Protocol for a Systematic Review.
    Wilson LA; Gandhi P
    JMIR Res Protoc; 2023 May; 12():e42417. PubMed ID: 37163329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral naltrexone as a treatment for relapse prevention in formerly opioid-dependent drug users: a systematic review and economic evaluation.
    Adi Y; Juarez-Garcia A; Wang D; Jowett S; Frew E; Day E; Bayliss S; Roberts T; Burls A
    Health Technol Assess; 2007 Feb; 11(6):iii-iv, 1-85. PubMed ID: 17280624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Barriers and facilitators to office-based opioid agonist therapy prescribing and effective interventions to increase provider prescribing: protocol for a systematic review.
    Nixon LL; Marlinga JC; Hayden KA; Mrklas KJ
    Syst Rev; 2019 Jul; 8(1):186. PubMed ID: 31345258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of adjunctive, personalised psychosocial intervention for non-response to opioid agonist treatment: Study protocol for a pragmatic randomised controlled trial.
    Marsden J; Stillwell G; Hellier J; Brown AM; Byford S; Kelleher M; Kelly J; Murphy C; Shearer J; Mitcheson L
    Contemp Clin Trials; 2017 Feb; 53():36-43. PubMed ID: 27940188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychological and psychosocial interventions for treatment-resistant schizophrenia: a systematic review and network meta-analysis.
    Salahuddin NH; Schütz A; Pitschel-Walz G; Mayer SF; Chaimani A; Siafis S; Priller J; Leucht S; Bighelli I
    Lancet Psychiatry; 2024 Jul; 11(7):545-553. PubMed ID: 38879276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological interventions for the treatment of delirium in critically ill adults.
    Burry L; Hutton B; Williamson DR; Mehta S; Adhikari NK; Cheng W; Ely EW; Egerod I; Fergusson DA; Rose L
    Cochrane Database Syst Rev; 2019 Sep; 9(9):CD011749. PubMed ID: 31479532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and cost-effectiveness of an adjunctive personalised psychosocial intervention in treatment-resistant maintenance opioid agonist therapy: a pragmatic, open-label, randomised controlled trial.
    Marsden J; Stillwell G; James K; Shearer J; Byford S; Hellier J; Kelleher M; Kelly J; Murphy C; Mitcheson L
    Lancet Psychiatry; 2019 May; 6(5):391-402. PubMed ID: 30952568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychosocial treatment for opiate abuse and dependence.
    Mayet S; Farrell M; Ferri M; Amato L; Davoli M
    Cochrane Database Syst Rev; 2005 Jan; (1):CD004330. PubMed ID: 15744796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Opioid Agonist Treatment With All-Cause Mortality and Specific Causes of Death Among People With Opioid Dependence: A Systematic Review and Meta-analysis.
    Santo T; Clark B; Hickman M; Grebely J; Campbell G; Sordo L; Chen A; Tran LT; Bharat C; Padmanathan P; Cousins G; Dupouy J; Kelty E; Muga R; Nosyk B; Min J; Pavarin R; Farrell M; Degenhardt L
    JAMA Psychiatry; 2021 Sep; 78(9):979-993. PubMed ID: 34076676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependence.
    Amato L; Minozzi S; Davoli M; Vecchi S
    Cochrane Database Syst Rev; 2011 Oct; (10):CD004147. PubMed ID: 21975742
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.